𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Altered fractionation and adjuvant chemotherapy for head and neck squamous cell carcinoma

✍ Scribed by William M. Mendenhall; Charles E. Riggs; Mikhail Vaysberg; Robert J. Amdur; John W. Werning

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
91 KB
Volume
32
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background

The aim of this review was to discuss the role of altered fractionation and adjuvant chemotherapy for patients treated with definitive radiotherapy (RT) for head and neck squamous cell carcinoma (HNSCC).

Methods

This review explores the pertinent literature and discusses the optimal management of previously untreated patients with stage III–stage IVA and/or ‐B HNSCCs.

Results

Depending on the schedule, altered fractionation improves locoregional control and survival. Both hyperfractionation and concomitant boost RT improve locoregional control and are associated with improved overall survival (OS). Adjuvant chemotherapy improves OS; the greatest impact is observed after concomitant versus induction or maintenance chemotherapy. Monochemotherapy appears to be equivalent to polychemotherapy. Drugs associated with the greatest survival benefit include fluorouracil and cisplatin. Intraarterial chemotherapy offers no advantage over intravenous chemotherapy. Concomitant cetuximab and RT results in improved outcomes similar to those observed after concomitant cisplatin‐based chemotherapy and RT.

Conclusions

Altered fractionation and/or concomitant chemotherapy result in improved outcomes compared with conventionally fractionated definitive RT alone for stage III–stage IV HNSCC. The optimal combination of RT fractionation and chemotherapy remains unclear. Β© 2009 Wiley Periodicals, Inc. Head Neck, 2009

πŸ“œ SIMILAR VOLUMES

MicroRNA alterations in head and neck sq
MicroRNA alterations in head and neck squamous cell carcinoma
✍ Steven S. Chang; Wei Wen Jiang; Ian Smith; Luana M. Poeta; Shahnaz Begum; Chad G πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 244 KB πŸ‘ 1 views

## Abstract MicroRNAs (mirs) are small noncoding RNA molecules (∼22 nucleotides) that regulate posttranscriptional gene expression. Currently, there has not been a comprehensive study of their role in primary head and neck squamous cell carcinoma (HNSCC). To determine the role of mirs in HNSCC, we

Chromosomal alterations during metastasi
Chromosomal alterations during metastasis formation of head and neck squamous cell carcinoma
✍ Ulrike BockmΓΌhl; Karsten SchlΓΌns; Sven Schmidt; Sabine Matthias; Iver Petersen πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 129 KB πŸ‘ 2 views

## Abstract Comparative genomic hybridization (CGH) was used to detect chromosomal changes during metastasis formation of head and neck squamous cell carcinomas (HNSCCs). In total, 92 tumors of 54 patients were investigated. In 34 of these, the metastases were compared to the corresponding primary

Microsatellite analysis and response to
Microsatellite analysis and response to chemotherapy in head-and-neck squamous-cell carcinoma
✍ HΓ©lΓ¨ne Blons; Arnauld Cabelguenne; FranΓ§oise Carnot; Ollivier Laccourreye; Isabe πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 144 KB πŸ‘ 2 views

Molecular studies have revealed that microsatellite instability and loss of heterozygosity occurred in head-and-neck cancer, suggesting the involvement both of suppressor and of mutator pathways in head-and-neck carcinogenesis. There is evidence for relations between tumor phenotype and clinical par

Head and neck squamous cell carcinoma in
Head and neck squamous cell carcinoma in childhood
✍ de Carvalho, Marcos Brasilino; Sobrinho, Josias de Andrade; Rapoport, AbrΓ£o; Fav πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 103 KB πŸ‘ 2 views

## Background: Squamous cell carcinoma (scc) of the head and neck region is rare in young patients and even less frequent in children 15 years or younger children. the patients reported in the literature are isolated cases and their management is always difficult because there is no large experienc

Proteomics: Clinical applications for he
Proteomics: Clinical applications for head and neck squamous cell carcinoma
✍ Wendell G. Yarbrough; Robbert J. C. Slebos; Daniel Liebler πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 222 KB πŸ‘ 2 views

The emerging field of proteomics offers great promise for unraveling the complex molecular events of tumorigenesis, as well as those that control clinically important tumor behaviors such as metastases, invasion, and resistance to therapy. Understanding the molecular basis of these tumor characteris